NASDAQ:ADMP
Delisted
Adamis Pharmaceuticals Corporation Stock News
$0.775
+0 (+0%)
At Close: Dec 06, 2023
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update
07:30am, Monday, 08'th Aug 2022
SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdo
What to Look For in a Penny Stock in 2022
03:30pm, Sunday, 31'st Jul 2022 PennyStocks
Are these tips part of your penny stocks trading strategy?
The post What to Look For in a Penny Stock in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
What to Look For in a Penny Stock in 2022
11:30am, Sunday, 31'st Jul 2022
Are these tips part of your penny stocks trading strategy? The post What to Look For in a Penny Stock in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
11:30am, Friday, 29'th Jul 2022 GlobeNewswire Inc.
Interim DSMB review expected in late September Interim DSMB review expected in late September
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
09:04am, Friday, 22'nd Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up peri
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
04:33pm, Thursday, 21'st Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days endin
What Makes Adamis (ADMP) a New Buy Stock
04:00pm, Tuesday, 31'st May 2022 Zacks Investment Research
Adamis (ADMP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Adamis (ADMP) a New Buy Stock
01:33pm, Tuesday, 31'st May 2022
Adamis (ADMP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Adamis Appoints Vickie Reed to Board of Directors
08:05pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
New Director Named with Significant Executive Management and Financial Leadership Experience New Director Named with Significant Executive Management and Financial Leadership Experience
Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and Growth
09:00pm, Wednesday, 18'th May 2022 GlobeNewswire Inc.
David J. Marguglio, Co-Founder and Chief Business Officer, Appointed President and CEO
Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q1 2022 Results - Earnings Call Transcript
09:28pm, Monday, 16'th May 2022
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP ) Q1 2022 Earnings Conference Call May 16, 2022 5:00 PM ET Corporate Participants Robert Uhl - ICR Westwicke Dennis Carlo - President and Chief Executiv
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
08:35pm, Monday, 16'th May 2022 GlobeNewswire Inc.
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET
Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business Update
09:56pm, Monday, 09'th May 2022 GlobeNewswire Inc.
SAN DIEGO, May 09, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overd
Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business Update
05:56pm, Monday, 09'th May 2022
SAN DIEGO, May 09, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdos
5 Winning Stocks to Land on the Overlooked Rising P/E Trick
09:03am, Monday, 09'th May 2022
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.